NSE Indices to remove Ennature Bio Pharma from several Nifty indices from November 17
Ennature Bio Pharma Ltd., listed following the demerger of India Glycols, is being removed from several Nifty indices for failing to meet the price band criteria. The change will take effect from November 17, 2026, removing the company from four indices, including Nifty Total Market.
Highlights
- Ennature Bio Pharma Ltd. will be removed from the Nifty Total Market, Nifty Microcap 250, Nifty Smallcap 500 and Nifty Sugar & Ethanol indices from November 17, 2026.
- The company did not hit its lower price band on two consecutive trading days on the NSE, November 12 and 13, 2026, prompting the removal.
- The removal will require portfolio rebalancing by investors and funds that track Nifty indices.
This article was translated from the original. Read the original version by our correspondent here.
Index changes and timeline
According to a press release issued by NSE India, the Index Maintenance Sub-Committee (Equity) of NSE Indices Ltd. has decided to remove Ennature Bio Pharma Ltd. from various indices because the company did not hit its lower price band on two consecutive trading days on the NSE, November 12, 2026 and November 13, 2026. The removal takes effect from November 17, 2026, meaning the change will be implemented after the market close on November 16, 2026.The company is being removed from Nifty Total Market, Nifty Microcap 250, Nifty Smallcap 500 and Nifty Sugar & Ethanol. NSE Indices also said that the removal will not be postponed further if Ennature Bio Pharma hits its lower price band on November 16, 2026.
Post-demerger listing and market impact
In an earlier press release dated August 26, 2026, NSE Indices Ltd. announced the inclusion of IGL Spirits Ltd. and Ennature Bio Pharma Ltd. in various indices with dummy symbols, following the demerger of the biopharma, spirits and biofuel businesses of India Glycols Ltd. The inclusion took effect from September 2, 2026, while both companies were listed on the NSE on November 4, 2026.Ennature Bio Pharma's removal from the indices matters to investors and funds that track Nifty indices, as it may require rebalancing their portfolios. The move also shows that index methodology price band rules continue to be strictly applied to newly listed companies following a demerger.
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
